Sage Journals: Discover world-class research

Open access

Review article

First published 2025

Genomics of ovarian cancers and the potential of precision medicine

Andrew Jarratt, Joseph Polidano, Clare L. Scott [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2025

Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer

Uma A. Mukherjee, Rowan E. Miller, Jonathan A. Ledermann

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-11

Prediction of homologous recombination deficiency from cancer gene expression data

Jun Kang, Jieun Lee, Ahwon Lee [...]

Journal of International Medical Research

Open access

Review article

First published 2024-11

Update on Combination Strategies of PARP Inhibitors

Zhuoqun Lin, Lingfang Wang, Ziyu Xing [...]

Cancer Control

Open access

Review article

First published 2018

Rucaparib in ovarian cancer: an update on safety,efficacy and place in therapy

Graziela Z. Dal Molin, Kohei Omatsu, Anil K. Sood [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data

Maher Albitar, Hong Zhang, Andrew Pecora [...]

Breast Cancer: Basic and Clinical Research

Open access

Research article

First published 2022

Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis

Liulu Zhang, Yuanqi Chen, Min-Yi Cheng [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2017-9

Niraparib in ovarian cancer: results to date and clinical potential

Davide Caruso, Anselmo Papa, Silverio Tomao [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2019

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer

Jonathan A. Ledermann, Eric Pujade-Lauraine

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-3

Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer

Jacopo Giuliani, Beatrice Mantoan, Lucrezia Ferrario [...]

Journal of Oncology Pharmacy Practice

Search results